Sustained response to Interferon α-2a in thalassemic patients with chronic hepatitis C. A prospective 8-year follow-up study

Haematologica

Volumn 90, Issue 1, 2005, Pages 129-131

  Syriopoulou, Vassiliki ^a   Daikos, George L ^b   Kostaridou, Stavroula L ^a   Manolaki, Nina ^a   Nakopoulou, Lydia ^c   Kattamis, Antonis ^a   Kattamis, Christos ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; RIBAVIRIN;

ADULT; ARTICLE; BLOOD TRANSFUSION; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMOLYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; RISK FACTOR; SPLENECTOMY; THALASSEMIA;

ADOLESCENT; ADULT; BETA-THALASSEMIA; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; MALE; PROSPECTIVE STUDIES; RNA, VIRAL;

EID: 13244275055     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Tine F, Magrin S, Craxi A, Pagliaro L. Interferon for non-A, non-B chronic hepatitis. A meta-analysis of randomised clinical trials. J Hepatol 1991;13:192-9.
2. Hoofnagle JH, di Bisceglie AM.The treatment of chronic viral hepatitis. N Engl J Med 1997;336:347-56.
3. Di Marco V, Lo Iacono O, Capra M, Grutta S, Ciaccio C, Gerardi C, et al. α-Interferon treatment of chronic hepatitis C in young patients with homozygous β-thalassemia. Haematologica 1992;77:502-6.
4. Donohue SM, Wonke B, Hoffbrand AV, Reittie J, Ganeshaguru K, Scheuer PJ, et al. α-interferon in the treatment of chronic hepatitis C infection in thalassaemia major. Br J Haematol 1993;83:491-7.
5. Di Marco V, Lo Iacono O, Almasio P, Ciaccio C, Capra M, Rizzo M, et al. Long-term efficacy of α-interferon in β-thalassemics with chronic hepatitis C. Blood. 1997;90:2207-12.
6. Giardini C, Galimberti M, Lucarelli G, Polchi P, Angelucci E, Baronciani D, et al. α-Interferon treatment of chronic hepatitis C after bone marrow transplantation for homozygous β-thalassemia. Bone Marrow Transplant 1997;20:767-2.
7. Spiliopoulou I, Repanti M, Katinakis S, Karana-Ginopoulou A. Papanastasiou DA. Response to interferon α-2b therapy in mutitransfused children with β-thalassemia and chronic hepatitis C. Eur J Clin Microbiol Infect Dis 1999;18:709-15.
8. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993;74:2391-9.
9. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
10. Li CK, Chan PK, Ling SC, Ha SY. Interferon and ribavirin as frontline treatment for chronic hepatitis C infection in thalassaemia major. Br J Haematol 2002;117:755-8.